Press "Enter" to skip to content

Biotech-for-hire PeptiDream charts new path and becomes short target

The promise of PeptiDream Inc’s drug-discovery technology and its lucrative research-for-hire contracts have made it a darling of the Tokyo stock market. Now, those gains have made it a target for short-seller Muddy Waters.

Source:: Technology News

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *